Minerva Neurosciences (NERV) Reports Q2 Loss of $0.27/Share

Minerva Neurosciences (NASDAQ: NERV) reported Q2 EPS of ($0.27), versus ($0.18) reported last year.

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
• Goldman Sachs reports global fund inflows for week of July 8
• Levi (LEVI) Tops Q2 EPS by 4c, Offers Guidance